Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 138,000 shares, an increase of 1,337.5% from the April 30th total of 9,600 shares. Approximately 1.9% of the company’s shares are sold short. […]
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 138,000 shares, a growth of 1,337.5% from the April 30th total of 9,600 shares. Currently, 1.9% of the shares of the stock are short sold. Based […]
SAN DIEGO, CA / ACCESSWIRE / May 28, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain
Ensysce Biosciences Regains Compliance with Nasdaq bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Ensysce Biosciences Continues Collaboration to Advance the Clinical pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.